Rachel Cohrs from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Rachel Cohrs STAT News Washington Correspondent @statnews. Washington, DC health policyjournalism	STAT+: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open - 6 months ago STAT+: Pharma giants, government spar in court over Medicare drug price negotiation - 6 months ago STAT+: White House touts incremental step in Medicare drug price negotiation: counteroffers - 7 months ago STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation - 7 months ago House looks to weaken Medicare negotiation - 7 months ago STAT+: Congress ditches site-neutral hospital pay policy - 7 months ago STAT+: Congress punts on PBM reform efforts - 7 months ago STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado - 7 months ago STAT+: San Diego biotech Neurocrine Biosciences joins PhRMA - 7 months ago Colorado could cap payments for Amgen’s Enbrel - 7 months ago STAT+: Lawmakers eye partial increase for Medicare doctor pay - 7 months ago STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices - 7 months ago STAT+: Senators start work on Medicare physician payment reform - 7 months ago STAT+: Key House Republican on health care plans exit from Congress - 7 months ago In a showy hearing, Bernie Sanders gets few answers about lower drug prices - 7 months ago New pharma CEOs in the hot seat - 7 months ago STAT+: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices - 7 months ago STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena - 8 months ago Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says - 8 months ago Bernie Sanders’ showdown with pharma CEOs is coming to a head - 8 months ago Will Congress get any health policy done this year? - 8 months ago Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices - 8 months ago STAT+: Courts will decide the future of Medicare’s power to negotiate drug prices within months - 8 months ago STAT+: Another major pharma company departs BIO - 9 months ago An ugly fight over care for the poor in Texas - 9 months ago STAT+: Texas taxpayers wanted to help the poor get health care. Instead, they’re funding a medical school at a wealthy university - 9 months ago STAT+: Inside Ascension’s legal fight with a Texas agency over caring for the poor - 9 months ago STAT+: Pharmacies fear New Year’s financial squeeze from Biden administration rule - 9 months ago House passes site-neutral policy, transparency, PBM reform package - 9 months ago STAT+: UnitedHealth executive to head health insurance group AHIP - 9 months ago Diabetes ‘epidemic’ gets a Senate hearing - 9 months ago STAT+: To lower drug prices, White House takes new aim at pharma patents - 9 months ago STAT+: Pfizer plans to depart BIO - 10 months ago STAT+: BIO selects rare disease advocate, biotech executive John Crowley as new CEO - 10 months ago Sweeping bill to fight opioid addiction will be considered by Senate health committee - 10 months ago STAT+: Senate Republicans throw cold water on so-called site-neutral hospital pay cuts - 10 months ago STAT+: Prominent pharmaceutical industry ally Anna Eshoo to retire - 10 months ago STAT+: Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing - 10 months ago STAT+: New NIH head says government has fallen behind pharma on clinical trials - 10 months ago What health policies could hitch a ride on a spending bill? - 10 months ago Medicare eligibility is tripping up the GOP presidential candidates - 10 months ago Republicans divided over financial crisis in Medicare - 10 months ago STAT+: Senate panel clears PBM reforms, safety-net hospital payments - 10 months ago STAT+: Medicare proceeds with plan to claw back hospital funds after Supreme Court decision - 11 months ago STAT+: Key Senate panel to consider PBM, drug pricing reform package - 11 months ago Senate committee plans Nov. 8 vote on wide-ranging health care package - 11 months ago Breaking down House Speaker Mike Johnson’s health care plan - 11 months ago STAT+: The health care issue Democrats can’t solve: hospital reform - 11 months ago The future of health care in the House - 12 months ago Senate HELP on collision course - 12 months ago
2	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Congress punts on PBM reform efforts - 7 months ago STAT+: Prominent pharmaceutical industry ally Anna Eshoo to retire - 10 months ago Senate committee plans Nov. 8 vote on wide-ranging health care package - 11 months ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado - 7 months ago
4	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: To lower drug prices, White House takes new aim at pharma patents - 9 months ago Republicans divided over financial crisis in Medicare - 10 months ago
5	Lev Facher STAT News	Sweeping bill to fight opioid addiction will be considered by Senate health committee - 10 months ago